National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Training, Career Development & Education Funding < Back to Main

Howard Temin Pathway to Independence Award in Cancer Research (K99/R00)




Introduction






NCI Special Notes






Funded K99/R00 Grants






Submitting an Application






Peer Review Process






Frequently Asked Questions






NCI Staff Contacts



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

NCI Research Coding and Reporting

NCI Launches Community Cancer Centers Pilot

The Nation's Investment in Cancer Research FY 2009

NCI Training and Career Development Inventory

New MERIT Award Winners Announced

caBIG: Connecting the Cancer Community

NCI Participation in the NIH Roadmap

Past Highlights
Introduction

The goal of the Pathway to Independence Award ( PI ) is to facilitate receiving an R01 award earlier in an investigator's research career and ultimately to increase and maintain a strong legion of new and talented NIH-supported independent investigators.

The PI award provides up to five years of support composed of two phases. The initial phase will provide 1-2 years of mentored support for highly promising, postdoctoral research scientists. The initial phase is followed by up to 3 years of independent support contingent on securing an independent research position. Award recipients will be expected to compete successfully for independent R01 support from the NIH during the career transition award period.

The PI Award is limited to researcher's holding doctoral degrees who have less than 5 years of research experience since their doctoral degree and are still in a mentored position. The initial application for the mentored phase may be submitted on behalf of the candidate (principal investigator) by any domestic for-profit or non-profit institution/organization such as universities, colleges, hospitals and laboratories, and eligible agencies of the Federal government, including NIH intramural laboratories. Foreign institutions are not eligible to apply.

The subsequent application for the independent phase may be submitted on behalf of the awardee (principal investigator) by any domestic for-profit or non-profit institution/organization such as universities, colleges, hospitals and laboratories at which the awardee has been recruited. Agencies of the Federal government (including NIH intramural laboratories) and foreign institutions are not eligible to apply for the independent phase of the PI award.

Applicants may submit only one PI Award application, and may not simultaneously submit applications or have awards pending for any other PHS career development award (K-series mechanisms). Up to two revisions of an application will be accepted. Pathway to Independence Awards are neither renewable nor transferable from one principal investigator to another.

Program Announcement

PA-07-297 NIH Pathway to Independence (PI) Award (K99/R00)

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov